Gilead Sciences
GILD
GILD
1,770 hedge funds and large institutions have $86.2B invested in Gilead Sciences in 2023 Q4 according to their latest regulatory filings, with 222 funds opening new positions, 652 increasing their positions, 694 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 652 | Existing positions reduced: 694
9% less call options, than puts
Call options by funds: $819M | Put options by funds: $902M
26% less funds holding in top 10
Funds holding in top 10: 31 → 23 (-8)
Holders
1,770
Holding in Top 10
23
Calls
$819M
Puts
$902M
Top Buyers
| 1 | +$1.45B | |
| 2 | +$262M | |
| 3 | +$183M | |
| 4 |
Neuberger Berman Group
New York
|
+$172M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$148M |
Top Sellers
| 1 | -$266M | |
| 2 | -$198M | |
| 3 | -$190M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$164M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$143M |